BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36951970)

  • 1. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study.
    Yamanaka-Takaichi M; Revankar R; Shih T; Gall M; Hsiao JL; Shi VY; Alavi A
    Arch Dermatol Res; 2023 Sep; 315(7):2129-2136. PubMed ID: 36951970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.
    Alavi A; Lynde C; Alhusayen R; Bourcier M; Delorme I; George R; Gooderham M; Gulliver W; Kalia S; Marcoux D; Poulin Y
    J Cutan Med Surg; 2017; 21(6):513-524. PubMed ID: 28639459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia.
    Eshmawi MT; Yousef Al-Mudaiheem H; Fatani M; Binamer Y; Alajlan M; Alharithy R; Alotaibi H; Almohanna HM; Alsantali A; Madani A; Al-Faraidy N; Bechara FG; Hamden Al-Jedaie A
    J Dermatolog Treat; 2024 Dec; 35(1):2353693. PubMed ID: 38862417
    [No Abstract]   [Full Text] [Related]  

  • 5. Diet in hidradenitis suppurativa: a review of published and lay literature.
    Silfvast-Kaiser A; Youssef R; Paek SY
    Int J Dermatol; 2019 Nov; 58(11):1225-1230. PubMed ID: 31006861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
    Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
    JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation.
    Kozera EK; Porter M; Paek SY; Mintoff D; McMeniman E; Oon HH; Chandran NS; Glasenhardt K; Ring HC; Frew JW
    Dermatology; 2024; 240(3):494-506. PubMed ID: 37963431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus.
    Bui H; Bechara FG; George R; Goldberg S; Hamzavi I; Kirby JS; Saylor D; Sayed CJ
    JAMA Dermatol; 2023 Apr; 159(4):441-447. PubMed ID: 36811866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary and metabolic factors in the pathogenesis of hidradenitis suppurativa: a systematic review.
    Choi F; Lehmer L; Ekelem C; Mesinkovska NA
    Int J Dermatol; 2020 Feb; 59(2):143-153. PubMed ID: 31651051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmacologic approaches for hidradenitis suppurativa - a systematic review.
    Hendricks AJ; Hirt PA; Sekhon S; Vaughn AR; Lev-Tov HA; Hsiao JL; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):11-18. PubMed ID: 31106609
    [No Abstract]   [Full Text] [Related]  

  • 12. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
    Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
    Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight Loss and Dietary Interventions for Hidradenitis Suppurativa: A Systematic Review.
    Sivanand A; Gulliver WP; Josan CK; Alhusayen R; Fleming PJ
    J Cutan Med Surg; 2020; 24(1):64-72. PubMed ID: 31502868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of International Management Guidelines for Hidradenitis Suppurativa.
    Hendricks AJ; Hsiao JL; Lowes MA; Shi VY
    Dermatology; 2021; 237(1):81-96. PubMed ID: 31645040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Impact of Dietary Avoidance among Individuals with Hidradenitis Suppurativa.
    Dempsey A; Butt M; Kirby JS
    Dermatology; 2020; 236(4):289-295. PubMed ID: 31678977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.
    Rick JW; De DR; Shih T; Alavi A; Kirby JS; Naik HB; Frew JW; Sayed CJ; Hsiao JL; Shi VY
    Skin Appendage Disord; 2022 Jul; 8(4):287-290. PubMed ID: 35979524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
    Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
    Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa.
    Prignano F; Pescitelli L; Giani I; Dini V; Romanelli M;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():21-24. PubMed ID: 31535762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.